Mettler-Toledo International Inc. (mtd)

MTD — Company Overview

Mettler-Toledo International Inc. (MTD) trades on NYQ as part of the Healthcare peer group (Diagnostics & Research).

MTD — Business Description

MTD represents a Diagnostics & Research business in the Healthcare segment. Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manag…

Official website: https://www.mt.com.

MTD — Investment Thesis

At a high level, MTD offers exposure to Healthcare with metrics outlined below from public market data.

• Revenue is expanding at roughly 4.5% year-over-year (public data).
• Trailing P/E of 33.60× sits in a moderate band relative to high-growth peers.
• Forward P/E (28.87×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $29.90B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

MTD — Financial Health

Key financial health indicators for Mettler-Toledo International Inc. are derived exclusively from public data — no proprietary estimates.

Profit margin of 21.9% indicates solid bottom-line conversion. Positive free cash flow of $693.59M supports balance-sheet flexibility. Debt-to-equity of 16668.45 warrants monitoring in a higher-rate environment.

MTD — Growth Outlook

Growth outlook for Mettler-Toledo International Inc. (MTD) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 4.5% suggests steady but measured expansion.
• Earnings growth of 18.3% year-over-year supports improving profitability.
• Price is 2.2% below the 52-week high.

MTD — Competitive Position

Mettler-Toledo International Inc. (MTD) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Diagnostics & Research.
• Market capitalization of $29.90B places MTD among large-cap peers.
• Gross margin near 60.3% may reflect pricing power or favorable mix.

MTD — Summary

Mettler-Toledo International Inc. (MTD) is a large-cap Healthcare company focused on Diagnostics & Research, listed on NYQ. Last price $1492.34 with market cap $29.90B. Trailing P/E 33.60×. Revenue grew 4.5% year-over-year per public data. Notable strengths include earnings growth of 18.3% year-over-year. Key watch items include elevated debt-to-equity (16668.45). Premium Terminal tools for Mettler-Toledo International Inc. add ownership analytics, news, and richer estimate history beyond this public summary.